Gadolinium enhanced MRI predicts clinical and MRI disease activity in relapsing-remitting multiple sclerosis.

T Koudriavtseva, A J Thompson, M Fiorelli, C Gasperini, S Bastianello, A Bozzao, A Paolillo, A Pisani, S Galgani, C Pozzilli

Department of Neurological Sciences, University of Rome La Sapienza, Italy.

The aim of the study was to evaluate the predictive power of baseline gadolinium (Gd) enhanced MRI in relation to subsequent clinical and MRI activity. Sixty eight patients with clinically definite relapsing-remitting multiple sclerosis had a baseline Gd enhanced MRI and were followed up clinically and by monthly Gd enhanced MRI for six months. The occurrence of relapses during the follow up period was predicted by the presence of at least one enhancing lesion on the baseline MRI (P < 0.05). The number and volume of enhancing lesions at baseline were significantly associated with both enhancing lesions observed during the follow up period (P < 0.0001) and the accumulation of abnormality on T2 weighted images (P < 0.0001). Moreover, the presence of three or more enhancing lesions at baseline scan was consistently associated with the development of permanent abnormalities on T2 weighted images six months later. The study suggests that the number and volume of Gd enhancing lesions at a single examination are strong short term predictors of subsequent clinical and MRI activity.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Okuda, D. T., Mowry, E. M., Beheshtian, A., Waubant, E., Baranzini, S. E., Goodin, D. S., Hauser, S. L., Pelletier, D. (2009). Incidental MRI anomalies suggestive of multiple sclerosis: The radiologically isolated syndrome. Neurology 72: 800-805 [Abstract] [Full Text]  
• Sormani, M. P., Rovaris, M., Comi, G., Filippi, M. (2007). A composite score to predict short-term disease activity in patients with relapsing-remitting MS. Neurology 69: 1230-1235 [Abstract] [Full Text]  
• Rashid, W, Davies, G R, Chard, D T, Griffin, C M, Altmann, D R, Thompson, A J, Miller, D H (2007). Relationship of triple dose contrast enhanced lesions with clinical measures and brain atrophy in early relapsing-remitting multiple sclerosis: a two-year longitudinal study. Mult Scler 13: 178-185 [Abstract]  
• Samijn, J P A, te Boekhorst, P A W, Mondria, T, van Doorn, P A, Flach, H Z, van der Meche, F G A, Cornelissen, J, Hop, W C, Lowenberg, B, Hintzen, R Q (2006). Intense T cell depletion followed by autologous bone marrow transplantation for severe multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 77: 46-50 [Abstract] [Full Text]  
• O'Connor, P., Miller, D., Riester, K., Yang, M., Panzara, M., Dalton, C., Miszkiel, K., Khan, O., Rice, G., Sheremata, W., International Natalizumab Trial Group, (2005). Relapse rates and enhancing lesions in a phase II trial of natalizumab in multiple sclerosis. Mult Scler 11: 568-572 [Abstract]  
• Pestalozza, I F, Pozzilli, C, Di Legge, S, Piattella, M C, Pantano, P, Caramia, F, Pasqualetti, P, Lenzi, G L (2005). Monthly brain magnetic resonance imaging scans in patients with clinically isolated syndrome. Mult Scler 11: 390-394 [Abstract]  
• He, J., Inglese, M., Li, B. S. Y., Babb, J. S., Grossman, R. I., Gonen, O. (2005). Relapsing-Remitting Multiple Sclerosis: Metabolic Abnormality in Nonenhancing Lesions and Normal-appearing White Matter at MR Imaging: Initial Experience. Radiology 234: 211-217 [Abstract] [Full Text]  
• Rizvi, S. A., Agius, M. A. (2004). Current approved options for treating patients with multiple sclerosis. Neurology 63: S8-S14 [Abstract] [Full Text]  
• Jeffery, D. R., Herndon, R. (2004). Review of mitoxantrone in the treatment of multiple sclerosis. Neurology 63: S19-S24 [Abstract] [Full Text]  
• Cohen, B. A., Khan, O., Jeffery, D. R., Bashir, K., Rizvi, S. A., Fox, E. J., Agius, M., Bashir, R., Collins, T. E., Herndon, R., Kinkel, P., Mikol, D. D., Picone, M. A., Rivera, V., Tornatore, C., Zwibel, H. (2004). Identifying and treating patients with suboptimal responses. Neurology 63: S33-S40 [Abstract] [Full Text]  
• Debouverie, M, Vandenberghe, N, Morrissey, S P, Anxionnat, R, Pittion-Vouyovitch, S, Vespignani, H, Edan, G (2004). Predictive parameters of mitoxantrone effectiveness in the treatment of multiple sclerosis. Mult Scler 10: 407-412 [Abstract]  
• Sardanelli, F., Iozzelli, A., Losacco, C., Murialdo, A., Filippi, M. (2003). Three Subsequent Single Doses of Gadolinium Chelate for Brain MR Imaging in Multiple Sclerosis. Am. J. Neuroradiol. 24: 658-662 [Abstract] [Full Text]  
• Rovaris, M., Comi, G., Ladkani, D., Wolinsky, J. S., Filippi, M. (2003). Short-Term Correlations between Clinical and MR Imaging Findings in Relapsing-Remitting Multiple Sclerosis. Am. J. Neuroradiol. 24: 75-81 [Abstract] [Full Text]  
• Panitch, H., Goodin, D.S., Francis, G., Chang, P., Coyle, P.K., O'Connor, P., Monaghan, E., Li, D., Weinshenker, B. (2002). Randomized, comparative study of interferon {beta}-1a treatment regimens in MS: The EVIDENCE Trial. Neurology 59: 1496-1506 [Abstract] [Full Text]  
• CHAMPS Study Group, (2002). MRI predictors of early conversion to clinically definite MS in the CHAMPS placebo group. Neurology 59: 998-1005 [Abstract] [Full Text]  
• Li, D. K.B., Zhao, G. J., Paty, D. W. (2001). Randomized controlled trial of interferon-beta-1a in secondary progressive MS: MRI results. Neurology 56: 1505-1513 [Abstract] [Full Text]  
• He, J., Grossman, R. I., Ge, Y., Mannon, L. J. (2001). Enhancing Patterns in Multiple Sclerosis: Evolution and Persistence. Am. J. Neuroradiol. 22: 664-669 [Abstract] [Full Text]  
• Koziol, J. A., Wagner, S., Sobel, D. F., Slivka, L. S., Romine, J. S., Sipe, J. C., Adams, H.-P. (2001). Predictive Value of Lesions for Relapses in Relapsing-remitting Multiple Sclerosis. Am. J. Neuroradiol. 22: 284-291 [Abstract] [Full Text]  
• Filippi, M (2000). Enhanced magnetic resonance imaging in multiple sclerosis. Mult Scler 6: 320-326 [Abstract]  
• Simon, J. H., Lull, J., Jacobs, L. D., Rudick, R. A., Cookfair, D. L., Herndon, R. M., Richert, J. R., Salazar, A. M., Sheeder, J., Miller, D., McCabe, K., Serra, A., Campion, M. K., Fischer, J. S., Goodkin, D. E., Simonian, N., Lajaunie, M., Wende, K., Martens-Davidson, A., Kinkel, R. P., Munschauer, F. E. III (2000). A longitudinal study of T1 hypointense lesions in relapsing MS: MSCRG trial of interferon {beta}-1a. Neurology 55: 185-192 [Abstract] [Full Text]  
• Nortvedt, M. W., Riise, T., Myhr, K.-M., Nyland, H. I. (2000). Quality of life as a predictor for change in disability in MS. Neurology 55: 51-54 [Abstract] [Full Text]  
• Bagnato, F, Tancredi, A, Richert, N, Gasperini, C, Bastianello, S, Bash, C, McFarland, H, Pozzilli, C, Frank, J A (2000). Contrast-enhanced magnetic resonance activity in relapsing remitting multiple sclerosis patients: a short term natural history study. Mult Scler 6: 43-49 [Abstract]  
• Paolillo, A., Coles, A. J., Molyneux, P. D., Gawne-Cain, M., MacManus, D., Barker, G. J., Compston, D. A. S., Miller, D. H. (1999). Quantitative MRI in patients with secondary progressive MS treated with monoclonal antibody Campath 1H. Neurology 53: 751-751 [Abstract] [Full Text]  
• Surensen, P. S. (1999). Biological markers in body fluids for activity and progression in multiple sclerosis. Mult Scler 5: 287-290 [Abstract]  
• Lee, M. A., Smith, S., Palace, J., Narayanan, S., Silver, N., Minicucci, L., Filippi, M., Miller, D. H., Arnold, D. L., Matthews, P. M. (1999). Spatial mapping of T2 and gadolinium-enhancing T1 lesion volumes in multiple sclerosis: evidence for distinct mechanisms of lesion genesis?. Brain 122: 1261-1270 [Abstract] [Full Text]  
• Simon, J. H., Jacobs, L. D., Campion, M. K., Rudick, R. A., Cookfair, D. L., Herndon, R. M., Richert, J. R., Salazar, A. M., Fischer, J. S., Goodkin, D. E., Simonian, N., Lajaunie, M., Miller, D. E., Wende, K., Martens-Davidson, A., Kinkel, R. P., Munschauer, F. E. III, Brownscheidle, C. M. (1999). A longitudinal study of brain atrophy in relapsing multiple sclerosis. Neurology 53: 139-139 [Abstract] [Full Text]  
• van Walderveen, M. A. A., Truyen, L., van Oosten, B. W., Castelijns, J. A., Lycklama a Nijeholt, G. J., van Waesberghe, J. H. T. M., Polman, C., Barkhof, F. (1999). Development of Hypointense Lesions on T1-Weighted Spin-Echo Magnetic Resonance Images in Multiple Sclerosis: Relation to Inflammatory Activity. Arch Neurol 56: 345-351 [Abstract] [Full Text]